<DOC>
	<DOCNO>NCT01170169</DOCNO>
	<brief_summary>This study examine bioequivalence Dr. Reddy 's Omeprazole delay release capsule fast condition .</brief_summary>
	<brief_title>Omeprazole Delayed Release ( DR ) Capsules Bioequivalence Study Dr. Reddys Under Fasting Conditions</brief_title>
	<detailed_description>This randomize , two-treatment , two-period , two-sequence , single dose , crossover bioequivalence study compare Omeprazole 40 mg Delayed Release Capsules ( Dr.Reddy 's Laboratories Ltd. , ) Prilosec® 40 mg ( Omeprazole Delayed Release Capsules ( manufacture Merck &amp; Co. , Inc. , USA ) 44 healthy , adult , human subject fast condition .</detailed_description>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Subjects provide write informed consent . Subjects healthy within 1845 year age , weigh least 50 kg . Body mass index ≥ 18 kglm2 ≤ 25 kg/m2 , body weight less 50 kg . Subjects normal health determine medical history physical examination perform within 15 day prior commencement study ( dose periodI ) . Subjects normal ECG , chest Xray ( PA view ) vital sign . Availability subject entire study period willingness adhere protocol requirement evidence write informed consent . Test product , dose , mode administration batch number</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>